11/17
07:36 am
carm
Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024 [Yahoo! Finance]
Medium
Report
Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024 [Yahoo! Finance]
11/17
07:30 am
carm
Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024
Medium
Report
Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024
11/8
07:30 am
carm
Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
Low
Report
Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
11/7
07:30 am
carm
Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Medium
Report
Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
11/5
09:05 am
carm
Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024
Medium
Report
Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024
11/1
07:23 am
carm
Carisma Therapeutics, Inc. (NASDAQ: CARM) was upgraded by analysts at EF Hutton Acquisition Co. I to a "strong-buy" rating.
Low
Report
Carisma Therapeutics, Inc. (NASDAQ: CARM) was upgraded by analysts at EF Hutton Acquisition Co. I to a "strong-buy" rating.
10/30
04:30 pm
carm
Carisma Therapeutics Announces Changes to its Board of Directors
Low
Report
Carisma Therapeutics Announces Changes to its Board of Directors
10/4
09:08 am
carm
Carisma Therapeutics Announces Upcoming Presentations at SITC 2024 [Yahoo! Finance]
Low
Report
Carisma Therapeutics Announces Upcoming Presentations at SITC 2024 [Yahoo! Finance]
10/4
09:05 am
carm
Carisma Therapeutics Announces Upcoming Presentations at SITC 2024
Low
Report
Carisma Therapeutics Announces Upcoming Presentations at SITC 2024
9/10
07:30 am
carm
Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases
High
Report
Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases
9/3
07:30 am
carm
Carisma Therapeutics to Present at Upcoming Conferences
Medium
Report
Carisma Therapeutics to Present at Upcoming Conferences